Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach
A legfontosabb adatok
- Ki végzi
- University of California, San Francisco
- Hol
- San Francisco (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 400 fő vett részt
- Kezdés
- 2023. nov. 27.
- Befejezés
- 2025. aug. 15.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoport
- A vizsgált kezelések
- CareConnect
- AutoReach
- Biospecimen samples
- A regiszteradat frissítve
- 2026. október 29.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 10 feltétel megnézéseKevesebb
Ki vehet részt
- Age 18 years and older
- Able to understand study procedures and to comply with them for the entire length of the study
- Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it
- English, Spanish, Cantonese, or Mandarin speaking
- Self-reported current use of tobacco, including e-cigarette on EHR
- Has a diagnosis of cancer
- Has been seen by a prescribing provider within a UCSF Cancer Center-affiliated clinical department within the past 3 months
Ki nem vehet részt
- Contraindication to any study-related procedure or assessment
- No valid contact telephone number
- Currently hospitalized or having been discharged from inpatient setting within the past month (according to EHR)
Helyszínek itt: Egyesült Államok
- University of California San FranciscoSan Francisco, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
This is a multi-arm, randomized controlled, pilot study which will recruit cancer patients who have been seen by a UCSF Cancer Center-affiliated clinical department to evaluate the efficacy of "CareConnect". This is the first study to assess the efficacy CareConnect, a combination of the Ask-Advise-Connect (AAC) with an Interactive Voice Response (IVR) delivering cancer-targeted educational messages to support referral to smoking cessation resources for patients with cancer.
A vizsgálat 2 csoportja
- CareConnect (Intervention)A vizsgált kezelés
Participants will receive automated 'CareConnect' calls/SMS text at enrollment. The call protocol includes up to 2 calls on 2 consecutive days if no response to first call. If there is no response to call, a follow up SMS 3-4 days later. Each CareConnect contact will include (1) assessment, (2) motivational enhancement tailored to participants' tobacco use status and importance of quitting; and (3) multiple referral options (UCSF Fontana Tobacco Treatment Center (FTTC)/tobacco treatment specialist, Quitline, or smoke-freeTXT from smokefree.gov), offered after the motivational enhancement message. CareConnect will notify UCSF tobacco treatment specialist of participants acceptance of any of referral options. Referral options will be documented by specialists on the participants electronic health record (EHR). Participants who have completed the CareConnect call will be contacted by research staff for a 3-month survey to be completed online, by telephone, or postal mail.
Kezelés: CareConnect és Biospecimen samples
- AutoReach (Control)Egyéb csoport
Participants will receive automated AutoReach calls/Short Message Service (SMS) text at enrollment provides one referral option (speaking with a tobacco treatment specialist) and an option for sending information on cessation resources. All participants who have completed the AutoReach call will be contacted by research staff for a 3-month survey to be completed online, by telephone or postal mail.
Kezelés: AutoReach és Biospecimen samples
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Connect Cancer Patients to Tobacco Cessation Care by Automated Interactive Outreach
- A regiszteradat frissítve
- 2026. október 29.